However, its impact on cancer immune infiltration and pan-cancer prognosis remains largely unexplored.<h4>Methods</h4>Pan-cancer multi-omics data from publicly available resources were systematically analyzed to evaluate TRIP13 expression across various cancer types and its association with patient prognosis. This evidence concerns the gene TRIP13 and cancer.